U.S. Hospitality Stock News

In early January 2026, Argent Trust Company, as Trustee of Sabine Royalty Trust, declared a cash distribution of US$0.321550 per unit, payable on January 29, 2026 to unit holders of record on January 15, 2026, alongside an update on December 2025 revenues and timing of certain cash receipts. The disclosure that approximately US$619,084 of January 2024 revenue would be recorded in February, with an additional US$455,454 already received after January’s close, highlights how reporting timing...

Why General Dynamics Stock Is Back in Focus General Dynamics (GD) is back on investors’ radar after its technology unit secured a US$988 million U.S. Navy contract to modernize fleet systems, along with broader optimism around potential increases in future defense spending. See our latest analysis for General Dynamics. The recent U.S. Navy contract and earlier optimism around proposed U.S. defense budget growth have come alongside a 7.7% 1 month share price return and a 39.9% 1 year total...

SELLAS Life Sciences Group announced an agreement with IMPACT-AML under which the pan-European network will run a clinical study of SLS009, a selective CDK9 inhibitor, in combination with azacitidine and venetoclax for newly diagnosed high-risk acute myeloid leukemia patients across multiple European sites. By tapping into IMPACT-AML’s EU Mission Cancer-backed STREAM platform, SELLAS can broaden European patient access to SLS009 in a cost-efficient way while its separate REGAL Phase 3 AML...

For investors wondering whether First Busey is offering fair value at its current share price, or whether the recent trading range is creating an opportunity, this article walks through what the numbers are indicating about the stock. The shares last closed at US$23.70, with returns of a 2.4% decline over 7 days and a 5.8% decline over 30 days, while the 1-year and 5-year returns of 9.9% and 23.2% keep longer term holders focused on the broader context. Recent coverage has focused on how...

Moderna (MRNA) is back in focus after its J.P. Morgan Healthcare Conference update, where management lifted the 2025 revenue forecast to about US$1.9b, outlined lower operating expenses, and reaffirmed its 2026 growth and 2028 cash breakeven targets. See our latest analysis for Moderna. The revenue upgrade and cost guidance from the J.P. Morgan Healthcare Conference has come alongside a sharp shift in sentiment. Moderna’s 1 day share price return of 17.02% has fed into a 30 day return of...

Lennar (LEN) is on investor watch after recent trading left the stock with a year-to-date total return of 18.3%, compared with a 0.4% total return over the past year. See our latest analysis for Lennar. The recent 1-day share price return of 2.0% and 7-day share price return of 15.95% at a share price of $123.32 sit against a much more muted 1-year total shareholder return of 0.41% and a 5-year total shareholder return of 83.33%. This suggests short-term momentum has picked up after a more...

If you are wondering whether CME Group's current share price really lines up with its underlying worth, you are not alone. This article is designed to walk you through that question step by step. The stock closed at US$268.45, with a 7 day return of a 0.3% decline, a 30 day return of a 1.9% decline, a year to date return of a 0.5% decline, but a 1 year return of 18.1%, a 3 year return of 70.6% and a 5 year return of 68.8%. Recent attention on CME Group has been shaped by its role as a major...

If you are wondering whether ImmunityBio's recent share price makes sense or not, you are not alone; the stock has attracted attention from investors trying to work out what a fair value might look like. The share price closed at US$2.82, with returns of 31.8% over the last 7 days, 19.5% over the last 30 days and 39.6% year to date, while the 1 year return sits at 21.6% and the 3 year return at negative 40.5%. Recent news flow around ImmunityBio has focused on its clinical pipeline and...

Concentrix (CNXC) closed out FY 2025 with Q4 revenue of US$2.6b and a basic EPS loss of US$23.83, alongside a net income loss of US$1.5b. On a trailing twelve month basis, revenue stood at US$9.8b with a net loss of US$1.3b and basic EPS of US$20.30. Over recent quarters the company has seen quarterly revenue move from US$2.4b in Q4 2024 to US$2.6b in Q4 2025. However, basic EPS shifted from US$1.73 and net income of US$111.0m in Q4 2024 to a sizable loss in the latest quarter, so the focus...

Intuit (INTU) has drawn fresh attention after BDO Canada LLP launched “BDO Powered by Intuit QuickBooks,” a joint offering that uses Intuit’s platform, automation, and AI-driven insights for Canadian small and mid-sized businesses. See our latest analysis for Intuit. The BDO partnership lands during a weaker patch for the stock, with a 1-month share price return of 9.78% decline and a year to date share price return of 3.84% decline, even as the 3-year total shareholder return of 58.20%...

If you are wondering whether Amkor Technology's current share price lines up with its underlying worth, you are not alone. This article walks through what that might look like using several valuation angles. At a last close of US$51.95, the stock has returns of 1.3% over 7 days, 17.2% over 30 days, 21.0% year to date, 108.2% over 1 year and 195.9% over 5 years. These figures may prompt questions about how much optimism or risk is now priced in. Recent coverage of Amkor has focused on its...

Earlier this month, UBS upgraded Altria Group to a buy rating, citing increased confidence in the company’s core tobacco operations and earnings visibility. UBS highlighted that cigarette volume declines may be easing and that industry conditions could become more supportive, potentially affecting how investors view Altria’s long-term cash generation and product mix. Next, we’ll explore how UBS’s view that cigarette volume declines may be easing could influence Altria’s existing investment...

If you are wondering whether Paylocity Holding's share price around US$144.74 offers good value today, it helps to separate the story from the numbers and look at what the data actually says. Over the last week the stock has recorded a 5.1% decline, while the 1 year return sits at a 24.7% decline. This may prompt questions about whether expectations or perceived risk have shifted. Recent commentary around Paylocity has focused on its position in payroll and human capital management software,...

RingCentral (RNG) has drawn fresh attention after appointing Mahmoud ElAssir to its Board of Directors, a technology and AI transformation leader currently serving as Senior Vice President and Chief Technology Officer at UnitedHealth Group. See our latest analysis for RingCentral. Against this appointment, RingCentral’s share price has been choppy, with a 1-day share price return of 3.49% decline and a 30-day share price return of 8.34% decline. The 1-year total shareholder return of 13.20%...

Netflix (NFLX) is back in focus after its latest reported figures, with investors weighing a share price near US$90 against revenue of US$43.4b and net income of US$10.4b. See our latest analysis for Netflix. At a share price of US$90.32, Netflix has seen a 24.94% 90 day share price decline even as its 1 year total shareholder return sits at 9.03% and the 3 year total shareholder return is approximately 18 times. If Netflix has you rethinking where growth and resilience might come from next,...

Dell Technologies (DELL) has put AI at the center of its story, raising its fiscal 2026 AI server sales forecast to US$25b, acquiring Dataloop, and rolling out the One Dell Way modernization program. See our latest analysis for Dell Technologies. Despite Dell’s busy year of AI focused product launches, acquisitions and the One Dell Way overhaul, momentum has cooled recently, with a 90 day share price return showing a 22.15% decline, even as the 5 year total shareholder return of 244.68%...

Recently, Tidewater outlined 2026 revenue guidance of US$1.32 billion to US$1.37 billion and confirmed it still has US$500 million available under its share repurchase authorization, against a backdrop of firmer crude oil prices and a softer U.S. jobs report that supported offshore energy sentiment. This combination of firmer long-term revenue expectations and potential capital returns has sharpened attention on how Tidewater might balance growth investment with shareholder-focused uses of...

The latest move from Cadence Design Systems (CDNS) centers on two product announcements that tie the business more tightly to AI hardware, including a new LPDDR5X memory IP solution with Microsoft as the first customer. See our latest analysis for Cadence Design Systems. Those AI focused launches come after a steady year in the market, with a 1 year total shareholder return of 9.81% and a 3 year total shareholder return of 86.77%, while the current share price sits at US$323.06. If Cadence’s...

Why Morgan Stanley Is Back On Investors’ Radar Morgan Stanley (MS) is drawing fresh attention as investors reassess its recent share performance in the context of its global wealth management, institutional securities, and investment management franchises. See our latest analysis for Morgan Stanley. Recent trading has been a bit choppy, with a 1-day share price return of a 2.04% decline and a 7-day share price return of a 2.66% decline, while a 90-day share price return of 12.36% alongside a...

Why the 24/7 Care upgrade matters for Teladoc Health stock Teladoc Health (TDOC) has rolled out a nationwide upgrade to its 24/7 Care service, expanding virtual urgent care to more conditions, adding real-time specialist consults, and integrating preventive care and prescription benefit checks. See our latest analysis for Teladoc Health. Even with the 24/7 Care upgrade and a recent appearance at the J.P. Morgan Healthcare Conference, Teladoc Health’s share price has been weak, with a 7 day...

Federal housing policy is back in focus after President Donald Trump directed the purchase of US$200b in mortgage bonds, a move aimed at lowering borrowing costs and directly affecting demand for builders such as D.R. Horton (DHI). See our latest analysis for D.R. Horton. The policy driven rebound that lifted D.R. Horton after the US$200b mortgage bond announcement comes on top of a 7 day share price return of 11.31% and a year to date share price return of 10.38%, while the 5 year total...

In early January 2026, Omnicom Group Inc. unveiled the next generation of its Omni marketing intelligence platform, integrating advanced AI, Acxiom RealID-powered identity data spanning 2.60 billion verified IDs, Flywheel Commerce Cloud signals, and autonomous agent systems into a unified operating system for marketers. This upgraded Omni platform uniquely combines one of the industry's most extensive consumer identity infrastructures with AI-native creative and media tools, aiming to give...

Wondering whether UP Fintech Holding offers genuine value at its current price, or if the recent excitement has already been priced in? This article breaks down what the numbers are saying about the stock. The share price sits at US$9.52 after a 7 day return of an 8.8% decline, a 30 day return of 3.0%, a year to date return of an 8.8% decline, a 1 year return of 54.5% and a 3 year return of 138.0%, while the 5 year return stands at a 36.2% decline. Recent coverage around UP Fintech Holding...

Constellation Brands (STZ) is back in focus after third quarter results topped expectations even as sales and profits softened, with management leaning on pricing, cost savings, dividends, and buybacks to steady the story. See our latest analysis for Constellation Brands. The latest results and capital return updates come after a mixed stretch for investors, with a 90 day share price return of 10.27% and an 8.49% year to date share price gain set against a 1 year total shareholder return of...